100 related articles for article (PubMed ID: 6282069)
1. AXC rat prostatic adenocarcinoma: characterization of cells in culture.
Shain SA; Boesel RW; Kalter SS; Heberling RL
Adv Exp Med Biol; 1981; 138():337-51. PubMed ID: 6282069
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and morphological characterization of clonal AXC rat prostate cancer cells.
Shain SA; Huot RI; Gorelic LS; Smith GC
Cancer Res; 1984 May; 44(5):2033-42. PubMed ID: 6713398
[TBL] [Abstract][Full Text] [Related]
3. Aging in the AXC rat: differential effects of chronic testosterone treatment on restoration of diminished prostate L-ornithine decarboxylase and S-adenosyl-L-methionine decarboxylase activities.
Shain SA; Moss AL
Endocrinology; 1981 Oct; 109(4):1184-91. PubMed ID: 7285866
[TBL] [Abstract][Full Text] [Related]
4. A x C rat prostate adenocarcinoma: initial characterization of testosterone regulation of hormone receptors of cultured cancer cells and derived tumors.
Shain SA; Boesel RW; Kalter SS; Heberling RL
J Natl Cancer Inst; 1981 Mar; 66(3):565-74. PubMed ID: 6259402
[TBL] [Abstract][Full Text] [Related]
5. Aging in the AXC rat: equivalence of the rates of inactivation of l-ornithine decarboxylase and S-adenosyl-L-methionine decarboxylase in prostate of young and aged rats.
Shain SA; Moss AL
Endocrinology; 1981 Oct; 109(4):1192-5. PubMed ID: 7285867
[TBL] [Abstract][Full Text] [Related]
6. Comparison of androgen regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase gene expression in rodent kidney and accessory sex organs.
Crozat A; Palvimo JJ; Julkunen M; Jänne OA
Endocrinology; 1992 Mar; 130(3):1131-44. PubMed ID: 1537280
[TBL] [Abstract][Full Text] [Related]
7. Aging in the AXC rat: diminished prostatic S-adenosyl-L-methionine decarboxylase (AMDC) activity appears to reflect altered expression of the AMDC gene.
Shain SA; Hilliard JK; de Leon C
Endocrinology; 1983 Oct; 113(4):1292-8. PubMed ID: 6193955
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of propagable cell lines (HUNC) from the androgen-sensitive Dunning R3327H rat prostatic adenocarcinoma.
Presnell SC; Borchert KM; Glover WJ; Gregory CW; Mohler JL; Smith GJ
Carcinogenesis; 1998 Apr; 19(4):585-90. PubMed ID: 9600341
[TBL] [Abstract][Full Text] [Related]
9. Altered androgen regulation of differentiated ventral prostate function during aging of the AXC rat.
Shain SA; Moss AL; Boesel RW; Lancaster CM
J Steroid Biochem; 1983 Jul; 19(1C):985-93. PubMed ID: 6887913
[TBL] [Abstract][Full Text] [Related]
10. Proliferation of AXC/SSh rat prostate cancer cells in vitro is androgen modulated.
Shain SA; Huot RI
J Steroid Biochem; 1987; 27(1-3):503-12. PubMed ID: 3320541
[TBL] [Abstract][Full Text] [Related]
11. Differential androgen modulation of AXC/SSh rat prostate cancer cell proliferation in vitro and its antagonism by antiandrogen.
Huot RI; Shain SA
Cancer Res; 1986 Aug; 46(8):3775-81. PubMed ID: 2942235
[TBL] [Abstract][Full Text] [Related]
12. Prostate carcinogenesis in the AXC rat.
Shain SA; McCullough B; Nitchuk M; Boesel RW
Oncology; 1977; 34(3):114-22. PubMed ID: 917441
[No Abstract] [Full Text] [Related]
13. Aging in the AXC/SSh rat: diminished prostate L-ornithine decarboxylase (ODC) activity reflects diminished prostate ODC protein and transcript content.
Shain SA; Schultz JJ; Lancaster CM
Endocrinology; 1986 Oct; 119(4):1830-8. PubMed ID: 2428603
[TBL] [Abstract][Full Text] [Related]
14. Effect of aging on AXC/SSh rat ventral and dorsolateral prostate S-adenosyl-L-methionine decarboxylase and L-ornithine decarboxylase messenger ribonucleic acid content.
Schultz JJ; Shain SA
Endocrinology; 1988 Jan; 122(1):120-6. PubMed ID: 2446853
[TBL] [Abstract][Full Text] [Related]
15. Effects of antisense RNA targeting of ODC and AdoMetDC on the synthesis of polyamine synthesis and cell growth in prostate cancer cells using a prostatic androgen-dependent promoter in adenovirus.
Li W; Liu X; Wang W; Sun H; Hu Y; Lei H; Liu G; Gao Y
Prostate; 2008 Sep; 68(12):1354-61. PubMed ID: 18548481
[TBL] [Abstract][Full Text] [Related]
16. Primary and transplantable adenocarcinomas of the A times C rat ventral prostate gland: morphologic characterization and examination of C19-steroid metabolism by early-passage tumors.
Shain SA; McCullough B; Nitchuk WM
J Natl Cancer Inst; 1979 Feb; 62(2):313-22. PubMed ID: 84089
[No Abstract] [Full Text] [Related]
17. Differential metabolism of dehydroepiandrosterone sulfate and estrogen conjugates by normal or malignant AXC/SSh rat prostate cells and effects of these steroid conjugates on cancer cell proliferation in vitro.
Huot RI; Shain SA
J Steroid Biochem; 1988 Jun; 29(6):617-21. PubMed ID: 2838688
[TBL] [Abstract][Full Text] [Related]
18. The relationship of androgen receptor levels to androgen responsiveness in the Dunning R3327 rat prostate tumor sublines.
Diamond DA; Barrack ER
J Urol; 1984 Oct; 132(4):821-7. PubMed ID: 6471235
[TBL] [Abstract][Full Text] [Related]
19. [Hormonal receptors and other procedures for predicting clinical response in cancer of the prostate].
Habib FK; Chisholm GD
Arch Esp Urol; 1984 Dec; 37 Suppl 2():751-9. PubMed ID: 6085672
[No Abstract] [Full Text] [Related]
20. Some effects of inhibitors of polyamine synthesis on experimental prostatic cancer.
Dunzendorfer U; Releyea N; Whitmore WF; Fogh J; Balis ME
Arzneimittelforschung; 1984; 34(1):36-9. PubMed ID: 6422951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
